Enzymedica introduced two phytosome formulas—one containing lemon balm for sleep and stress, the other palmitoylethanolamide (PEA) for joint mobility—claiming clinical improvements in sleep quality and PEA absorption respectively. Phytosome technology complexes botanical compounds with phospholipids to enhance bioavailability, a formulation approach relevant to practitioners seeking delivery optimization for plant-derived compounds.
Key Points
- Lemon balm phytosome formulation claims threefold improvement in sleep quality
- PEA phytosome achieves sixfold better absorption versus standard micronized form
- Phospholipid pairing technology designed to enhance botanical compound bioavailability
Longevity Analysis
Sleep quality and joint function represent measurable pillars of healthspan maintenance. The absorption differential demonstrated for PEA—a naturally occurring lipid signaler involved in tissue recovery and inflammatory modulation—illustrates how formulation strategy can determine whether an active compound reaches its target tissue in clinically relevant concentrations. For lemon balm, the capacity to support sleep without exogenous melatonin speaks to supporting the body's own signaling mechanisms rather than replacing them. Both products address recovery capacity at the cellular level, though clinical efficacy claims warrant independent verification beyond company-sponsored studies.
Original published by Longevity.Technology.